JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Search

Cronos Group Inc

Gesloten

SectorGezondheidszorg

2.45 -3.54

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.43

Max

2.54

Belangrijke statistieken

By Trading Economics

Inkomsten

-46M

-38M

Verkoop

12M

44M

K/W

Sectorgemiddelde

50.8

77.256

Winstmarge

-86.961

Werknemers

459

EBITDA

-35M

-35M

Dividenden

By Dow Jones

Volgende Winsten

6 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

194M

973M

Vorige openingsprijs

5.99

Vorige sluitingsprijs

2.45

Nieuwssentiment

By Acuity

50%

50%

153 / 373 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Cronos Group Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 nov 2025, 23:57 UTC

Winsten

Naver's Third-Quarter Earnings Rose on AI Push

4 nov 2025, 23:10 UTC

Acquisities, Fusies, Overnames

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4 nov 2025, 23:48 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

4 nov 2025, 23:48 UTC

Marktinformatie

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4 nov 2025, 23:37 UTC

Marktinformatie

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4 nov 2025, 23:30 UTC

Winsten

Itau Unibanco 3Q Net BRL33.7B >ITUB

4 nov 2025, 23:25 UTC

Winsten

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4 nov 2025, 23:25 UTC

Winsten

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4 nov 2025, 23:24 UTC

Winsten

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4 nov 2025, 23:23 UTC

Winsten

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4 nov 2025, 23:06 UTC

Winsten

Review & Preview: Tech Check -- Barrons.com

4 nov 2025, 22:52 UTC

Winsten

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4 nov 2025, 22:33 UTC

Winsten

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4 nov 2025, 22:29 UTC

Winsten

Ashland 4Q Adj EPS $1.08 >ASH

4 nov 2025, 22:29 UTC

Winsten

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4 nov 2025, 22:28 UTC

Winsten

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4 nov 2025, 22:27 UTC

Winsten

Ashland 4Q Cont Ops EPS 73c >ASH

4 nov 2025, 22:27 UTC

Winsten

Ashland 4Q EPS 71c >ASH

4 nov 2025, 22:27 UTC

Winsten

Ashland 4Q Sales $478M >ASH

4 nov 2025, 22:23 UTC

Winsten

Ovintiv 3Q EPS 57c >OVV

4 nov 2025, 22:19 UTC

Marktinformatie

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4 nov 2025, 22:16 UTC

Winsten

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4 nov 2025, 22:14 UTC

Acquisities, Fusies, Overnames

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4 nov 2025, 22:13 UTC

Acquisities, Fusies, Overnames

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4 nov 2025, 22:13 UTC

Acquisities, Fusies, Overnames

Consortium: Able to Finance a Deal With Available Liquidity

4 nov 2025, 22:12 UTC

Acquisities, Fusies, Overnames

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4 nov 2025, 22:11 UTC

Winsten

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4 nov 2025, 22:11 UTC

Acquisities, Fusies, Overnames

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4 nov 2025, 22:10 UTC

Acquisities, Fusies, Overnames

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 22:07 UTC

Winsten

Kinross Gold Raises Dividend to $0.035 >K.T

Peer Vergelijking

Prijswijziging

Cronos Group Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

1.84 / N/ASteun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

153 / 373 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Cronos Group Inc

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
help-icon Live chat